Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma
Digestive and Liver Disease · 2025-02 · 57 · S31
DOI: 10.1016/j.dld.2025.01.059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025-02. Verfasst von S. Ascari und 28 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ascari, S., Chen, R., Iavarone, M., Stefanini, B., Marra, F., Cabibbo, G., Vivaldi, C., Palloni, A., Soldà, C., Ponziani, F., Valenzi, E., Ravaioli, F., Franceschini, E., Tosetti, G., Campani, C., Celsa, C., Masi, G., Brandi, G., Lonardi, S., …, & Tovoli, F. (2025). Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma. Digestive and Liver Disease, 57, S31. https://doi.org/10.1016/j.dld.2025.01.059
Vancouver
Ascari S, Chen R, Iavarone M, Stefanini B, Marra F, Cabibbo G, et al. Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma. Digestive and Liver Disease. 2025;57:S31. doi:10.1016/j.dld.2025.01.059
BibTeX
@article{Ascari2025,
author = {Ascari, S. and Chen, R. and Iavarone, M. and Stefanini, B. and Marra, F. and Cabibbo, G. and Vivaldi, C. and Palloni, A. and Soldà, C. and Ponziani, F.R. and Valenzi, E. and Ravaioli, F. and Franceschini, E. and Tosetti, G. and Campani, C. and Celsa, C. and Masi, G. and Brandi, G. and Lonardi, S. and Stella, L. and Pressiani, T. and Lani, L. and Dalbeni, A. and Svegliati-Baroni, G. and Federico, P. and Ielasi, L. and Lorenzo, S. De and Piscaglia, F. and Tovoli, F.},
title = {Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma},
journal = {Digestive and Liver Disease},
year = {2025},
volume = {57},
pages = {S31},
doi = {10.1016/j.dld.2025.01.059}
}
EUVIMED